Wells Fargo’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Wells Fargo’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-63,924	Closed	-$3.42M	–	6771
2016 Q1	$3.42M	Sell	63,924 -2,153	-3%	-$159K	﹤0.01%	2559
2015 Q4	$7.46M	Buy	66,077 +5,625	+9%	+$620K	﹤0.01%	2051
2015 Q3	$7.12M	Buy	60,452 +5,292	+10%	+$691K	﹤0.01%	2055
2015 Q2	$4.27M	Sell	55,160 -1,338	-2%	-$87.7K	﹤0.01%	2526
2015 Q1	$3.27M	Sell	56,498 -1,928	-3%	-$81.9K	﹤0.01%	2673
2014 Q4	$1.89M	Sell	58,426 -4,151	-7%	-$125K	﹤0.01%	3048
2014 Q3	$1.53M	Buy	62,577 +10,338	+20%	+$210K	﹤0.01%	3174
2014 Q2	$926K	Buy	52,239 +246	+0.5%	+$3.96K	﹤0.01%	3577
2014 Q1	$1.04M	Buy	51,993 +48,693	+1,476%	+$944K	﹤0.01%	3467
2013 Q4	$55K	Buy	+3,300	New	+$45.7K	﹤0.01%	4719

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Wells Fargo's ANAC Position: Q2 2016 in Review

Wells Fargo sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 63,924 shares — an estimated $3.42M sold.

Wells Fargo first reported a position in ANAC in Q4 2013 and held it in 10 quarters. The position peaked at $7.46M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Wells Fargo reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Wells Fargo sold 63,924 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $3.42M.
Wells Fargo first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2013 and held it in 10 quarters.
Wells Fargo's ANACOR PHARMACEUTICALS INC COM position peaked at $7.46M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Wells Fargo's 13F filing for Q2 2016, filed 11 Aug 2016.